Provided by Tiger Trade Technology Pte. Ltd.

ProQR Therapeutics NV

2.38
-0.0500-2.06%
Post-market: 2.390.0100+0.42%17:05 EDT
Volume:2.18M
Turnover:5.03M
Market Cap:335.86M
PE:-5.20
High:2.43
Open:2.42
Low:2.24
Close:2.43
52wk High:3.10
52wk Low:1.33
Shares:141.12M
Float Shares:101.18M
Volume Ratio:1.56
T/O Rate:2.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4578
EPS(LYR):-0.4702
ROE:-57.40%
ROA:-19.76%
PB:3.62
PE(LYR):-5.06

Loading ...

ProQR Therapeutics Q1 Basic EPS EUR -0.13

THOMSON REUTERS
·
May 12

ProQR to present Axiomer RNA editing data at upcoming scientific conferences

Reuters
·
May 11

ProQR Therapeutics NV expected to post a loss of 12 cents a share - Earnings Preview

Reuters
·
May 04

ProQR Therapeutics announces annual shareholder meeting

Reuters
·
May 04

ProQR Announces Nomination of DR. Lykke Hinsch Gylvin to Its Board of Directors

THOMSON REUTERS
·
Apr 30

ProQR spotlights AX-0810 milestones at investor and analyst event

Reuters
·
Apr 09

BRIEF-Proqr Announces Partnership With Ginkgo Bioworks And Formation Of Ai Advisory Board

Reuters
·
Apr 08

ProQR partners with Ginkgo Bioworks to scale AI-enabled RNA editing discovery

Reuters
·
Apr 08

ProQR Announces Partnership With Ginkgo Bioworks and Formation of AI Advisory Board

THOMSON REUTERS
·
Apr 08

ProQR Therapeutics Nv - Expects First AI-Discovered Development Candidate to Enter Clinic in 2026

THOMSON REUTERS
·
Apr 08

ProQR Therapeutics Nv - Ginkgo Bioworks Makes Strategic Equity Investment in ProQR

THOMSON REUTERS
·
Apr 08

ProQR Therapeutics to host virtual investor and analyst event; pipeline spotlight to include AX-0810 indication update

Reuters
·
Mar 25

ProQR Therapeutics’ Chief Scientific Officer Gerardus Johannes Platenburg files initial beneficial ownership statement

Reuters
·
Mar 19

ProQR Therapeutics NV Director Domenico Valerio Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

ProQR Therapeutics NV CFO Dennis Hom files initial beneficial ownership statement

Reuters
·
Mar 19

ProQR Therapeutics director Alison Frances Lawton files Form 3 initial beneficial ownership statement

Reuters
·
Mar 19

ProQR Therapeutics NV Director Theresa Heggie files initial beneficial ownership statement

Reuters
·
Mar 19

ProQR Therapeutics NV Director Bart Filius Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19

ProQR Therapeutics NV CEO and Director Daniel Anton de Boer files initial beneficial ownership statement

Reuters
·
Mar 19

ProQR Therapeutics NV Director Begona Carreno-Gomez Files Initial Beneficial Ownership Statement

Reuters
·
Mar 19